Drug Type Small molecule drug |
Synonyms LNK 008, LNK008 |
Target |
Action modulators |
Mechanism MAPKAPK2 modulators(MAP kinase-activated protein kinase 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Discovery | China | 01 Dec 2024 |